Chemokine News and Research

RSS
Chemokines are a family of small cytokines, or proteins secreted by cells. Proteins are classified as chemokines according to shared structural characteristics such as small size (they are all approximately 8-10 kilodaltons in size), and the presence of four cysteine residues in conserved locations that are key to forming their 3-dimensional shape.
Protein-based CHD risk score developed

Protein-based CHD risk score developed

Scientists identify on/off obesity-induced switch to slow cancer progression

Scientists identify on/off obesity-induced switch to slow cancer progression

Maternal immune dysfunction linked to risk of autism with intellectual disability in children

Maternal immune dysfunction linked to risk of autism with intellectual disability in children

Elevated endothelial progenitor cells may characterise PAH patients

Elevated endothelial progenitor cells may characterise PAH patients

HDAC inhibitors could improve activity of immunotherapeutic antibodies in lung cancer patients

HDAC inhibitors could improve activity of immunotherapeutic antibodies in lung cancer patients

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Inherited gene after black plague may help treat HIV patients co-infected with hepatitis C

Inherited gene after black plague may help treat HIV patients co-infected with hepatitis C

Study opens new avenues for treatment of prostate cancer in obese patients

Study opens new avenues for treatment of prostate cancer in obese patients

Scientists demonstrate workings of CCL2 mechanism that stimulates nerve regeneration

Scientists demonstrate workings of CCL2 mechanism that stimulates nerve regeneration

MD Anderson study reveals MDSCs as likely target for developing prostate cancer treatments

MD Anderson study reveals MDSCs as likely target for developing prostate cancer treatments

TaiGen releases Taigexyn (nemonoxacin) capsules in Taiwan

TaiGen releases Taigexyn (nemonoxacin) capsules in Taiwan

Adelaide researchers identify key protein involved in 'super-inflammatory' immune response

Adelaide researchers identify key protein involved in 'super-inflammatory' immune response

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Multiple IV administration of adipose-derived MSCs may extend healthy life and lifespan

Multiple IV administration of adipose-derived MSCs may extend healthy life and lifespan

New UTMB study reveals mechanism central to pollen-induced allergies

New UTMB study reveals mechanism central to pollen-induced allergies

Wayne State researcher receives $1.9 million grant to improve EPCs-based cell therapy for vascular diseases

Wayne State researcher receives $1.9 million grant to improve EPCs-based cell therapy for vascular diseases

3SBio obtains ex-China global rights to Apexigen's anti-TNF mAb technology

3SBio obtains ex-China global rights to Apexigen's anti-TNF mAb technology

Scientists reveal new combination method that efficiently destroys cancer cells

Scientists reveal new combination method that efficiently destroys cancer cells

Findings could lead to new therapies that stop breast cancer progression

Findings could lead to new therapies that stop breast cancer progression

Researchers discover new source for cells that can develop into coronary vessels

Researchers discover new source for cells that can develop into coronary vessels

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.